BioCentury
ARTICLE | Company News

Santaris, Roche deal

August 11, 2014 7:00 AM UTC

Roche will acquire partner Santaris for $250 million in cash up front and up to $200 million in undisclosed milestones. Santaris is using its locked nucleic acid (LNA) platform to develop antisense dr...